The Claim
In adults aged 45–90, plasma concentrations of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and phosphorylated tau (p-tau181) exhibit accelerated increases between ages 68 and 71, indicating a population-level inflection point in neurodegenerative and glial activation processes during late midlife.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Between ages 68 and 71, levels of three biological markers in the blood—GFAP, NfL, and p-tau181—rise more rapidly in adults aged 45 to 90, signaling a shift in brain aging processes at the population level.
See the scientific wording
In a population-based cohort of adults aged 45–90, plasma glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and phosphorylated tau (p-tau181) show accelerated increases in concentration around ages 68–71, suggesting a population-level inflection point in neurodegenerative and glial activation processes during late midlife.
As people age, proteins in the brain start to misfold and stick together, which activates support cells in the brain and damages nerve fibers. This causes specific proteins to leak into the blood, and their levels rise sharply around age 68 to 71.
What the research says
1 studyAround age 68 to 71, the levels of certain blood proteins that signal brain damage and inflammation start rising much faster in most people, and this study found exactly that.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.